A subset of dendritic cells induces CD4+ T cells to produce IFN-γ by an IL-12-independent but CD70-dependent mechanism in vivo

Journal of Experimental Medicine

Volumn 204, Issue 5, 2007, Pages 1095-1106

  Soares, Helena ^a   Waechter, HaeNa ^a   Glaichenhaus, Nicholas ^b   Mougneau, Evelyne ^b   Yagita, Hideo ^c   Mizenina, Olga ^a   Dudziak, Diana ^a   Nussenzweig, Michel C ^a   Steinman, Ralph M ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

^c JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CD70 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; LACK PROTEIN; PROTOZOAL PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL ISOLATION; CELL MATURATION; CELL SURFACE; CYTOKINE PRODUCTION; DENDRITIC CELL; HELPER CELL; IN VIVO STUDY; LEISHMANIA MAJOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD; ANTIGENS, CD70; ANTIGENS, PROTOZOAN; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERFERON TYPE II; INTERLEUKIN-12; LECTINS, C-TYPE; LYMPHOCYTE SUBSETS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PROTOZOAN PROTEINS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION;

EID: 34248997138     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20070176     Document Type: Article

References (65)

1. Abbas, A.K., K.M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature. 383:787-793.
2. O'Garra, A. 1998. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity. 8:275-283.
3. Murphy, K.M., and S.L. Reiner. 2002. The lineage decisions of helper T cells. Nat. Rev. Immunol. 2:933-944.
4. Shankaran, V., H. Ikeda, A.T. Bruce, J.M. White, P.E. Swanson, L.J. Old, and R.D. Schreiber. 2001. IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature. 410:1107-1111.
5. Mosmann, T.R., and R.L. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.
6. Cohn, L., J.A. Elias, and G.L. Chupp. 2004. Asthma: mechanisms of disease persistence and progression. Annu. Rev. Immunol. 22:789-815.
7. Powrie, F., and R.L. Coffman. 1993. Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol. Today. 14:270-274.
8. Pulendran, B. 2004. Modulating vaccine reponses with dendritic cells and toll-like receptors. Immunol. Rev. 199:227-250.
9. Moser, M. 2003. Dendritic cells in immunity and tolerance-do they display opposite functions? Immunity. 19:5-8.
10. Hawiger, D., K. Inaba, Y. Dorsett, K. Guo, K. Mahnke, M. Rivera, J.V. Ravetch, R.M. Steinman, and M.C. Nussenzweig. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194:769-780.
11. + T cell tolerance. J. Exp. Med. 196:1627-1638.
12. Bonifaz, L.C., D.P. Bonnyay, A. Charalambous, D.I. Darguste, S. Fujii, H. Soares, M.K. Brimnes, B. Moltedo, T.M. Moran, and R.M. Steinman. 2004. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med. 199:815-824.
13. + T cell immunity at a mucosal surface after a single dose of anti-dendritic cell HIV gag fusion antibody vaccine. J. Exp. Med. 203:607-617.
14. + T cells from T cell receptor transgenic mice. J. Exp. Med. 176:1091-1098.
15. Pulendran, B., J. Lingappa, M.K. Kennedy, J. Smith, M. Teepe, A. Rudensky, C.R. Maliszewski, and E. Maraskovsky. 1997. Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. J. Immunol. 159:2222-2231.
16. + T cells. J. Immunol. 154:5071-5079.
17. Heufler, C., F. Koch, U. Stanzl, G. Topar, M. Wysocka, G. Trinchieri, A. Enk, R.M. Steinman, N. Romani, and G. Schuler. 1996. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur. J. Immunol. 26:659-668.
18. Moser, M., and K.M. Murphy. 2000. Dendritic cell regulation of Th1-Th2 development. Nat. Immunol. 1:199-205.
19. Jiang, W., W.J. Swiggard, C. Heufler, M. Peng, A. Mirza, R.M. Steinman, and M.C. Nussenzweig. 1995. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature. 375:151-155.
20. Vremec, D., M. Zorbas, R. Scollay, D.J. Saunders, C.F. Ardavin, L. Wu, and K. Shortman. 1992. The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells. J. Exp. Med. 176:47-58.
21. + dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192:1685-1696.
22. + dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J. Exp. Med. 195:1289-1302.
23. + dendritic cells in cross-presentation is not dictated by antigen capture. Proc. Natl. Acad. Sci. USA. 103:10729-10734.
24. Nussenzweig, M.C., R.M. Steinman, J.C. Unkeless, M.D. Witmer, B. Gutchinov, and Z.A. Cohn. 1981. Studies of the cell surface of mouse dendritic cells and other leukocytes. J. Exp. Med. 154:168-187.
25. Crowley, M., K. Inaba, M. Witmer-Pack, and R.M. Steinman. 1989. The cell surface of mouse dendritic cells: FACS analyses of dendritic cells from different tissues including thymus. Cell. Immunol. 118:108-125.
26. Dudziak, D., A.O. Kamphorst, G.F. Heidkamp, V. Buchholz, C. Trumpfheller, S. Yamazaki, C. Cheong, K. Liu, H.W. Lee, C.G. Park, et al. 2007. Differential antigen processing by dendritic cell subsets in vivo. Science. 315:107-111.
27. - subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 189:587-592.
28. Pulendran, B., J.L. Smith, G. Caspary, K. Brasel, D. Pettit, E. Maraskovsky, and C.E. Maliszweski. 1999. Distinct dendritic cell subsets differentially regulate the class of immune responses in vivo. Proc. Natl. Acad. Sci. USA. 96:1036-1041.
29. Reis e Sousa, C., G. Yap, O. Schulz, N. Rogers, M. Schito, J. Aliberti, S. Hieny, and A. Sher. 1999. Paralysis of dendritic cell IL-12 production by microbial products prevents infection-induced immunopathology. Immunity. 11:637-647.
30. Hochrein, H., K. Shortman, D. Vremec, B. Scott, P. Hertzog, and M. O'Keeffe. 2001. Differential production of IL-12, IFN-α, and IFN-γ by mouse dendritic cell subsets. J. Immunol. 166:5448-5455.
31. Doffinger, R., E. Jouanguy, F. Altare, P. Wood, T. Shirakawa, F. Novelli, D. Lammas, D. Kumararatne, and J.L. Casanova. 1999. Inheritable defects in interleukin-12- and interferon-gamma-mediated immunity and the TH1/TH2 paradigm in man. Allergy. 54:409-412.
32. Fieschi, C., S. Dupuis, E. Catherinot, J. Feinberg, J. Bustamante, A. Breiman, F. Altare, R. Baretto, F. Le Deist, S. Kayal, et al. 2003. Low penetrance, broad resistance, and favorable outcome of interleukin 12 recep tor β1 deficiency: medical and immunological implications. J. Exp. Med. 197:527-535.
33. -/- setting. Immunity. 16:429-439.
34. + T cells: evidence for two distinct pathways for promoter activation. Eur. J. Immunol. 29:548-555.
35. Noble, A., M.J. Thomas, and D.M. Kemeny. 2001. Early Th1/Th2 cell polarization in the absence of IL-4 and IL-12: T cell receptor signaling regulates the response to cytokines in CD4 and CD8 T cells. Eur. J. Immunol. 31:2227-2235.
36. Mullen, A.C., F.A. High, A.S. Hutchins, H.W. Lee, A.V. Villarino, D.M. Livingston, A.L. Kung, N. Cereb, T.P. Yao, S.Y. Yang, and S.L. Reiner. 2001. Role of T-bet in commitment of Th1 cells before IL-12-dependent selection. Science. 292:1907-1910.
37. Amsen, D., J.M. Blander, G.R. Lee, K. Tanigaki, T. Honjo, and R.A. Flavell. 2004. Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell. 117:515-526.
38. Trinchieri, G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3:133-146.
39. Mougneau, E., F. Altare, A.E. Wakil, S. Zheng, T. Coppola, Z.-E. Wang, R. Waldmann, R.M. Locksley, and N. Glaichenhaus. 1995. Expression cloning of a protective Leishmania antigen. Science. 268:563-565.
40. Heinzel, F.P., R.M. Rerko, F. Ahmed, and E. Pearlman. 1995. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. J. Immunol. 155:730-739.
41. Sypek, J.P., C.L. Chung, S.E.H. Mayor, J.M. Subramanyam, S.J. Goldman, D.S. Sieburth, S.F. Wolf, and R.G. Schaub. 1993. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177:1797-1802.
42. Park, A.Y., B.D. Hondowicz, and P. Scott. 2000. IL-12 is required to maintain a Th1 response during Leishmania major infection. J. Immunol. 165:896-902.
43. Sacks, D., and N. Noben-Trauth. 2002. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2:845-858.
44. Boscardin, S.B., J.C. Hafalla, R.F. Masilamani, A.O. Kamphorst, H.A. Zebroski, U. Rai, A. Morrot, F. Zavala, R.M. Steinman, R.S. Nussenzweig, and M.C. Nussenzweig. 2006. Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses. J. Exp. Med. 203:599-606.
45. + T cell expansion with variable dependence on type I IFN. J. Exp. Med. 199:775-784.
46. Fearon, D.T., and R.M. Locksley. 1996. The instructive role of innate immunity in the acquired immune response. Science. 272:50-54.
47. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251-276.
48. Watts, T.H. 2005. TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23:23-68.
49. Fujii, S., K. Liu, C. Smith, A.J. Bonito, and R.M. Steinman. 2004. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J. Exp. Med. 199:1607-1618.
50. + T cells. J. Immunol. 174:710-717.
51. Hintzen, R.Q., S.M.A. Lens, K. Lammers, H. Kuiper, M.P. Beckmann, and R.A.W. van Lier. 1995. Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation. J. Immunol. 154:2612-2623.
52. Taraban, V.Y., T.F. Rowley, and A. Al-Shamkhani. 2004. A critical role for CD70 in CD8 T cell priming by CD40-licensed APCs. J. Immunol. 173:6542-6546.
53. + antigen-presenting cells control the proliferation and differentiation of T cells in the intestinal mucosa. Nat. Immunol. 6:698-706.
54. + T cell-mediated alloimmune responses in vivo. J. Immunol. 174:1357-1364.
55. Carr, J.M., M.J. Carrasco, J.E. Thaventhiran, P.J. Bambrough, M. Kraman, A.D. Edwards, A. Al-Shamkhani, and D.T. Fearon. 2006. CD27 mediates interleukin-2-independent clonal expansion of the CD8+ T cell without effector differentiation. Proc. Natl. Acad. Sci. USA. 103:19454-19459.
56. Iwamoto, S., M. Ishida, K. Takahashi, K. Takeda, and A. Miyazaki. 2005. Lipopolysaccharide stimulation converts vigorously washed dendritic cells (DCs) to nonexhausted DCs expressing CD70 and evoking long-lasting type 1 T cell responses. J. Leukoc. Biol. 78:383-392.
57. Iwamoto, S., M. Ishida, S. Tamaoki, T. Hagiwara, H. Sueki, and A. Miyazaki. 2004. A human Langerhans cell-like cell line, ELD-1, promotes CD8 T cells to produce IFN-γ through CD70-dependent alternative pathway. Cell. Immunol. 232:49-56.
58. Sanchez, P.J., J.A. McWilliams, C. Haluszczak, H. Yagita, and R.M. Kedl. 2007. Combined TLR/CD40 stimulation mediates potent cellular immunity by regulating dendritic cell expression of CD70 in vivo. J. Immunol. 178:1564-1572.
59. Schnurr, M., Q. Chen, A. Shin, W. Chen, T. Toy, C. Jenderek, S. Green, L. Miloradovic, D. Drane, I.D. Davis, et al. 2005. Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery. Blood. 105:2465-2472.
60. Hendriks, J., L.A. Gravestein, K. Tesselaar, R.A.W. van Lier, T.N.M. Schumacher, and J. Borst. 2000. CD27 is required for generation and long-term maintenance of T cell immunity. Nat. Immunol. 1:433-440.
61. Matter, M., B. Odermatt, H. Yagita, J.M. Nuoffer, and A.F. Ochsenbein. 2006. Elimination of chronic viral infection by blocking CD27 signaling. J. Exp. Med. 203:2145-2155.
62. Xiao, Y., J. Hendriks, P. Langerak, H. Jacobs, and J. Borst. 2004. CD27 is acquired by primed B cells at the centroblast stage and promotes germinal center formation. J. Immunol. 172:7432-7441.
63. Belz, G.T., C.M. Smith, L. Kleinert, P. Reading, A. Brooks, K. Shortman, F.R. Carbone, and W.R. Heath. 2004. Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus. Proc. Natl. Acad. Sci. USA. 101:8670-8675.
64. Granelli-Piperno, A., A. Pritsker, M. Pack, I. Shimeliovich, J.-F. Arrighi, C.G. Park, C. Trumpfheller, V. Piguet, T.M. Moran, and R.M. Steinman. 2005. Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction. J. Immunol. 175:4265-4273.
65. Heath, A.W., W.W. Wu, and M.C. Howard. 1994. Monoclonal anti-bodies to murine CD40 define two distinct functional epitopes. Eur. J. Immunol. 24:1828-1834.